Drug treatment of connective tissue disease.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D003095:Collagen Diseases / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D010615:Phenacetin / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D006046:Gold; D002738:Chloroquine; D003520:Cyclophosphamide; D010615:Phenacetin; D010653:Phenylbutazone; D010396:Penicillamine; D001379:Azathioprine; D001241:Aspirin; D007213:Indomethacin